Larimar Therapeutics (LRMR) Earnings Date & Reports

A.I. Advisor

published Earnings

LRMR is expected to report earnings to rise 10.91% to -37 cents per share on November 12

Larimar Therapeutics LRMR Stock Earnings Reports

Q3'24

Est.

$-0.38

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.05

Q3'23

Beat

by $0.01

The last earnings report on August 07 showed earnings per share of -34 cents, missing the estimate of -30 cents. With 788.44K shares outstanding, the current market capitalization sits at 567.88M.

View a ticker or compare two or three

Compare

LRMR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LRMR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for LRMR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Three Bala Plaza East

Phone

+1 844 511-9056

Employees

Web

https://www.larimartx.com